RoC has launched its Derm Correxion Franchise—and RoC Derm Correxion Fill + Treat Serum is the brand’s first launch.

The product will be showcased at this year’s American Academy of Dermatology (AAD) Annual Meeting March 25-29, 2022 in Boston, Massachusetts.

RoC Derm Correxion Fill + Treat serum is a non-invasive wrinkle filling treatment that targets the appearance of stubborn lines instantly and over time using a patent-pending 3D approach that works deep within skin’s surface, targeting all layers.
 
“As a leader in Retinol for decades, RoC continues to research and innovate on this gold standard of anti-aging, pushing the boundaries to provide lasting skin health and beauty benefits,” says Art Pellegrino, Senior Vice President of R&D at RoC Skincare. “With the launch of Derm Correxion, we are excited to leverage new data from our research on Retinol’s increased efficacy when formulated with Hyaluronic Acid.”

RoC Derm Correxion is the culmination of a multi-year research and development program in partnership with an advisory board of dermatologists and plastic surgeons.

“We created this line as an affordable, accessible option for consumers to experience the instant benefits of a highly effective wrinkle-filling treatment. We are honored to have partnered with top skincare medical professionals in the field to bring our vision and our Brand’s dermatologist-recommended heritage to life,” says Fernando Acosta, CEO of RoC Skincare.

RoC Skincare will be present at the AAD meeting for dermatologists interested in a first look at the new science and innovation presented by the brand.

Consumers can now purchase RoC Derm Correxion Fill + Treat Serum at Walmart and on the RoC e-commerce site.

The collection will roll out nationally with additional innovation at major food, drug and mass retailers by September 2022.

 

 

 

 

View this post on Instagram

 

 

 

 

 

 

 

 

 

 

 

A post shared by RoC Skincare (@rocskincare)